1. Home
  2. MFC vs COR Comparison

MFC vs COR Comparison

Compare MFC & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFC
  • COR
  • Stock Information
  • Founded
  • MFC 1887
  • COR 2001
  • Country
  • MFC Canada
  • COR United States
  • Employees
  • MFC N/A
  • COR N/A
  • Industry
  • MFC Life Insurance
  • COR Other Pharmaceuticals
  • Sector
  • MFC Finance
  • COR Health Care
  • Exchange
  • MFC Nasdaq
  • COR Nasdaq
  • Market Cap
  • MFC 51.8B
  • COR 44.4B
  • IPO Year
  • MFC 1999
  • COR N/A
  • Fundamental
  • Price
  • MFC $30.61
  • COR $242.06
  • Analyst Decision
  • MFC Strong Buy
  • COR Buy
  • Analyst Count
  • MFC 2
  • COR 11
  • Target Price
  • MFC $37.50
  • COR $268.09
  • AVG Volume (30 Days)
  • MFC 1.5M
  • COR 1.2M
  • Earning Date
  • MFC 02-19-2025
  • COR 02-05-2025
  • Dividend Yield
  • MFC 3.73%
  • COR 0.91%
  • EPS Growth
  • MFC 28.88
  • COR N/A
  • EPS
  • MFC 2.09
  • COR 7.53
  • Revenue
  • MFC $22,266,553,157.00
  • COR $293,958,599,000.00
  • Revenue This Year
  • MFC N/A
  • COR $9.98
  • Revenue Next Year
  • MFC $9.81
  • COR $6.47
  • P/E Ratio
  • MFC $14.08
  • COR $32.14
  • Revenue Growth
  • MFC 15.83
  • COR 12.12
  • 52 Week Low
  • MFC $20.96
  • COR $214.77
  • 52 Week High
  • MFC $33.07
  • COR $253.27
  • Technical
  • Relative Strength Index (RSI)
  • MFC 48.89
  • COR 64.12
  • Support Level
  • MFC $29.41
  • COR $233.61
  • Resistance Level
  • MFC $31.25
  • COR $241.14
  • Average True Range (ATR)
  • MFC 0.46
  • COR 3.94
  • MACD
  • MFC 0.05
  • COR 1.86
  • Stochastic Oscillator
  • MFC 64.95
  • COR 91.11

About MFC Manulife Financial Corporation

Manulife Financial provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. Its investment management business contributes approximately 20% of its earnings and has around CAD 1.05 trillion in assets under management and administration as of the end of 2023. The US business, which primarily operates under the John Hancock brand, contributes about 27% of earnings and is mainly focused on providing insurance products for estate, business, and income protection. The Asia segment provides insurance products and insurance-based wealth accumulation products in over 11 countries and contributes around 30% of earnings. The Canadian business segment contributes approximately 23% of earnings.

About COR Cencora Inc.

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: